Skip to main content
. Author manuscript; available in PMC: 2016 Jun 22.
Published in final edited form as: J Cancer Stem Cell Res. 2015 Feb 27;3:e1003. doi: 10.14343/JCSCR.2015.3e1003

Figure 2. Resistance of CD133+ cells to TMZ.

Figure 2

Sorted U87 and T98G cells were transfected with anti-miR-9 or untransfected. The cells were treated with 200 μM TMZ. After 72 h, cell viability was assayed by CytoTox 96® LDH release. The results are presented as % cell death±SD, n ¼ 4. *p < 0.05 vs. CD133− cells. ** p > 0.05 vs. untransfected CD133+ cells.